Learn More
Invitrogen™ NONO Monoclonal Antibody (78-1 C)

Description
MA3-2024 detects the nmt55/p54nrb in human, rat and rabbit samples. MA3-2024 has been successfully used in immunohistochemistry, immunoprecipitation, and Western blot procedures. By Western blot, this antibody detects a ~55 kDa protein representing nmt55/p54nrb in MCF-7 cells, human breast tumor cells, rat uterine tissue, and rabbit liver extracts. In immunohistochemistry this antibody recognizes the nmt55/p54nrb in MCF-7 cells and human breast tumor cells. This monoclonal antibody has been referred to as NMT-1. The MA3-2024 immunogen is a synthetic peptide corresponding to residues T(140) V R E A G P P A F Y R P N S(154) of human ER alpha.
Specifications
Specifications
| Antigen | NONO |
| Applications | Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot, RNA Immunoprecipitation |
| Classification | Monoclonal |
| Clone | 78-1 C |
| Concentration | Conc. Not Determined |
| Conjugate | Unconjugated |
| Formulation | Ascites with 0.05% sodium azide |
| Gene | Nono |
| Gene Accession No. | Q15233, Q5FVM4 |
| Gene Alias | 54 kDa nuclear RNA- and DNA-binding protein; 55 kDa nuclear protein; AA407051; AV149256; DNA-binding p52/p100 complex, 52 kDa subunit; HGNC:7871; LOC100346936; MRXS34; NMT-1; NMT55; nonA; Nono; NonO protein; non-POU domain containing octamer binding; non-POU domain containing, octamer-binding; non-POU domain-containing octamer (ATGCAAAT) binding protein; non-POU domain-containing octamer-binding protein; non-POU-domain-containing; non-POU-domain-containing, octamer binding protein; non-POU-domain-containing, octamer-binding protein; NRB54; P54; p54(nrb); p54nrb; PPP1R114; protein phosphatase 1, regulatory subunit 114 |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.